ID   HS-ES-2M
AC   CVCL_8714
SY   HSES2M
DR   CLO; CLO_0050149
DR   BioSample; SAMN03471971
DR   GEO; GSM2409682
DR   GEO; GSM2409683
DR   GEO; GSM2409684
DR   GEO; GSM2409685
DR   GEO; GSM2409686
DR   GEO; GSM2409687
DR   GEO; GSM2787356
DR   RCB; RCB2360
DR   Wikidata; Q54006384
RX   PubMed=28945250;
CC   Population: Japanese.
CC   Sequence variation: Gene deletion; HGNC; HGNC:11103; SMARCB1; Zygosity=Heterozygous (PubMed=28945250).
CC   Omics: Genomics; ChIP-seq; H3K27ac.
CC   Omics: Genomics; ChIP-seq; H3K27me3.
CC   Omics: Genomics; ChIP-seq; H3K4me3.
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: Metastatic; Lung; UBERON=UBERON_0002048.
ST   Source(s): RCB=RCB2360
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 12
ST   D16S539: 10,11
ST   D5S818: 11
ST   D7S820: 8
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 17,18
DI   NCIt; C3714; Epithelioid sarcoma
DI   ORDO; Orphanet_293202; Epithelioid sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_8715 ! HS-ES-2R
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 21
//
RX   PubMed=28945250; DOI=10.1038/ng.3958; PMCID=PMC5803080;
RA   Nakayama R.T., Pulice J.L., Valencia A.M., McBride M.J.,
RA   McKenzie Z.M., Gillespie M.A., Ku W.L., Teng M.-X., Cui K.-R.,
RA   Williams R.T., Cassel S.H., Qing H., Widmer C.J., Demetri G.D.,
RA   Irizarry R.A., Zhao K.-J., Ranish J.A., Kadoch C.;
RT   "SMARCB1 is required for widespread BAF complex-mediated activation of
RT   enhancers and bivalent promoters.";
RL   Nat. Genet. 49:1613-1623(2017).
//